BBNX
Beta Bionics, Inc. Common Stock
NASDAQ: BBNX · HEALTHCARE · MEDICAL DEVICES
$9.90
-1.79% today
Updated 2026-04-29
Market cap
$441.16M
P/E ratio
—
P/S ratio
4.00x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$9 – $33
Volume
1.2M
Beta Bionics, Inc. Common Stock (BBNX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-60.21M | $-32.45M | $-48.27M | $-50.92M |
| Capital expenditures | $772000.00 | $402000.00 | $3.40M | $5.30M |
| Depreciation | — | — | — | — |
| Stock-based comp | $6.10M | $5.66M | $6.38M | $16.38M |
| Free cash flow | $-60.98M | $-32.85M | $-51.67M | $-56.22M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |